Nemaura’s current* pipeline includes development of devices and formulations for both internal programs and clients. The combined pipeline includes molecules for the following indications: - CNS disorders
- Inflammation
- Pain management
- Non-invasive glucose monitoring
- Non-invasive lactate monitoring
*Last updated January 2012
To discuss your topical or transdermal product development needs please contact our Technical and Business Development Manager, Dr Richard Toon: rctoon@nemaura.co.uk |